RoosterBio & MBL Beijing Biotech Partner to Accelerate Advanced Therapy Manufacturing in China August 30, 2022
RoosterBio & AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell & Exosome Therapies August 16, 2022
ShiftBio Partners with RoosterBio to Accelerate Development of a Novel Genetically Engineered Exosome, SBI-102 for Rare Diseases & Cancer April 26, 2022
Univercells Technologies Partners with RoosterBio to Advance Scalable & Continuous Exosomes Manufacture January 20, 2022
RoosterBio Names Life Science Industry Leader, Timothy M. Kelly, Ph.D., as New Chief Executive Officer October 5, 2021
RoosterBio Releases RoosterGEM™, Cell & Gene Therapy’s First Complete Transduction Medium May 20, 2021
RoosterBio Launches Next Generation EV Collection Media as Part of a Complete hMSC-EV Production System December 16, 2020
